| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.43 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |